(firstQuint)Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency.

 In this open study, patients will enter a baseline period of 6 days where the pancreatic enzyme therapy will be discontinued and a standard diet given.

 After the baseline period, patients will enter a treatment period of 6 days where a fixed dose of BSSL will be administered.

 The primary efficacy measurements will be made by collecting stool during the last three days of each period.

.

 Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency@highlight

The purpose of this study is to evaluate the efficacy in patients with cystic fibrosis and pancreatic insufficiency following treatment with BSSL